Held in conjunction with the American Diabetes Association’s 2026 Scientific Sessions
Saturday, June 6, 2026
6:15 PM – 6:30 PM CT Registration & Dinner
6:30 PM – 8:00 PM CT CE Symposium
Hilton New Orleans Riverside
Two Poydras Street
New Orleans, Louisiana 70130
Meeting Room: St. James Ballroom
PROGRAM FEATURES
- Downloadable animations
- Interactive, case-based learning environment
- Create-your-own personalized poster
PRESENTING FACULTY
 |
Emily K. Sims, MD, MS Associate Professor of Pediatrics Pediatric Endocrinology and Diabetology Indiana University School of Medicine Center for Diabetes and Metabolic Diseases Indianapolis, Indiana |
 |
Jay H. Shubrook, DO, FAAFP, FACOFP Professor and Diabetologist Department of Clinical Sciences and Community Health Touro University California Vallejo, California |
PROGRAM OVERVIEW
This symposium will provide a practical overview of early detection and disease‑modifying therapies across the type 1 diabetes (T1D) continuum, featuring expert faculty insights alongside a powerful patient perspective. Faculty will discuss current evidence and guidelines for identifying at‑risk individuals, applying therapies that can delay disease progression, as well as exploring emerging strategies to preserve beta‑cell function in new‑onset T1D.
Key Topics include:
- Evidence‑based approaches to screening and early detection
- Practical considerations for implementing disease‑modifying therapies in presymptomatic T1D
- Emerging strategies to preserve beta‑cell function in new‑onset T1D
- A patient perspective offering real‑world context on challenges and decision-making
- Interactive, case‑based discussions that translate evidence to practice
Designed to be engaging and clinically relevant, this program equips participants with actionable insights to improve care throughout the T1D continuum.
LEARNING OBJECTIVES:
After completing the CME activity, learners should be better able to:
- Implement risk-based screening approaches to facilitate timely identification of presymptomatic T1D.
- Analyze T1D screening results to determine disease stage and inform appropriate monitoring and referral decisions.
- Develop individualized treatment strategies that incorporate disease-modifying therapies to delay T1D progression in eligible patients.
- Recognize the importance of beta-cell preservation on T1D prognosis and outcomes.
- Review emerging approaches aimed at beta cell preservation & their potential future application in new-onset T1D
TARGET AUDIENCE
This activity is designed to meet the educational needs of multidisciplinary clinicians who refer, treat or see patients with or at high risk for T1D is needed, including primary care clinicians, pediatricians, pediatric & adult endocrinologists, diabetes educators, infusion professionals and other allied healthcare professionals.
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this live activity for a maximum of 1.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the live activity.
NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of up to 1.5 ANCC contact hours.
COMMISSION ON DIETETIC REGISTRATION (CDR) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of 1.5 CPEU.
ACCME INNOVATION PARTNER
Med Learning Group (MLG) is proud to be recognized as an ACCME Innovation Partner, leading the way in simplifying CME for physicians. As an Innovation Partner, MLG will be working with the ACCME by submitting credits directly to CME Passport.
PHYSICIAN DISCLAIMER: Upon your acceptance in the evaluation and completion of this CME activity, Med Learning Group will share your completion information and certain personal details (e.g., name, National Provider Identifier, birthdate MM/DD) with the ACCME for inclusion in your CME Passport transcript and, as applicable, reporting to certifying, licensing, or other regulatory authorities you specify.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CE questions, please contact Med Learning Group at [email protected]
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event Staff will be glad to assist you with any special needs (eg, physical, dietary, etc). Please contact Med Learning Group prior to the live event at [email protected]
